Home
>
National Drug Code (NDC)
>
Vascepa
Vascepa - 52937-001-21 - (icosapent ethyl)
Drug Information of Vascepa
| Product NDC: | 52937-001 |
| Proprietary Name: | Vascepa |
| Non Proprietary Name: | icosapent ethyl |
| Active Ingredient(s): | 1000 mg/1 & nbsp; icosapent ethyl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vascepa
| Product NDC: | 52937-001 |
| Labeler Name: | Amarin Pharma Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202057 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121001 |
Package Information of Vascepa
| Package NDC: | 52937-001-21 |
| Package Description: | 120 CAPSULE in 1 BOTTLE (52937-001-21) |
NDC Information of Vascepa
| NDC Code | 52937-001-21 |
| Proprietary Name | Vascepa |
| Package Description | 120 CAPSULE in 1 BOTTLE (52937-001-21) |
| Product NDC | 52937-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | icosapent ethyl |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121001 |
| Marketing Category Name | NDA |
| Labeler Name | Amarin Pharma Inc. |
| Substance Name | ICOSAPENT ETHYL |
| Strength Number | 1000 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
